Abstract:
Antimicrobial resistance (AMR) has emerged as one of the most pressing global health threats of the 21st century, compromising the effective prevention and treatment of infectious diseases. The rapid rise of multidrug-resistant pathogens demands innovative, data-driven approaches that extend beyond conventional diagnostic and therapeutic strategies. Artificial Intelligence (AI), with its ability to analyse vast and complex healthcare datasets, offers transformative opportunities in the fight against AMR.
This presentation explores the expanding role of AI in antimicrobial stewardship, rapid pathogen identification, resistance prediction, and precision therapeutics. Machine learning and deep learning algorithms can process microbiological, genomic, pharmacological, and clinical data to identify resistance patterns with remarkable speed and accuracy. AI-powered diagnostic platforms enable early detection of resistant organisms, thereby facilitating timely intervention and optimized antibiotic selection.
In addition, AI-driven predictive models enhance surveillance systems by forecasting resistance trends, detecting outbreaks, and supporting public health decision-making. These tools can improve hospital infection control practices, guide empirical therapy, and reduce inappropriate antibiotic prescribing. AI also contributes to drug discovery by accelerating the identification of novel antimicrobial compounds and optimizing existing treatment regimens.
Despite its immense promise, the integration of AI into AMR management requires careful attention to data quality, model transparency, ethical considerations, and regulatory compliance. Interdisciplinary collaboration among clinicians, pharmacists, microbiologists, data scientists, and policymakers is essential to ensure successful implementation.
In conclusion, AI represents a paradigm shift in addressing antimicrobial resistance by enabling faster diagnostics, smarter surveillance, and personalized antimicrobial therapy. Harnessing AI responsibly can significantly strengthen global efforts to combat AMR, improve patient outcomes, and safeguard the efficacy of antibiotics for future generations.
Biography:
I am an academician, researcher, and healthcare educator with expertise in pharmacology, artificial intelligence in healthcare, and antimicrobial resistance. I have published numerous research papers in peer-reviewed national and international journals, and one of my patents has been published. My research focuses on integrating innovative technologies into healthcare to improve patient outcomes and promote safer therapeutic practices. I am deeply committed to advancing healthcare awareness, particularly among tribal and underserved communities, and have conducted multiple educational programs on antibiotic stewardship in schools and colleges. Despite challenges, I remain steadfast in my mission to create meaningful impact through education, research, and community service. I have also participated as a speaker in international scientific forums, including virtual global seminars.
